Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Cancer Immunol Res ; 4(1): 72-82, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26603620

ABSTRACT

Freeze-dried black raspberries (BRB), their component anthocyanins (AC), and a metabolite of BRB ACs, protocatechuic acid (PCA), inhibit the development of esophageal cancer in rats induced by the carcinogen, N-nitrosomethylbenzylamine (NMBA). All three components reduce inflammation in the esophagus and in plasma. The present study determined the relation of changes in inflammatory markers to infiltration of innate immune cells into NMBA-treated esophagus. Rats were injected with NMBA (0.35 mg/kg) for 5 weeks while on control diet. Following NMBA treatment, rats were fed diets containing 6.1% BRB powder, an AC-rich fraction of BRBs (3.8 µmol/g), or 500 ppm PCA. At weeks 15, 25, and 35, inflammatory biomarker expression in the plasma and esophagus was quantified, and infiltration of immune cells in the esophagus was examined. At all three time points, BRB, AC, and PCA similarly affected cytokine production in the esophagus and plasma of NMBA-treated rats, relative to the NMBA-only control. These included decreased expression of the proinflammatory cytokine IL1ß and increased expression of the anti-inflammatory cytokine IL10. Moreover, all three diets also increased the expression of IL12, a cytokine that activates both cytolytic natural killer and CD8(+) T cells. In addition, the three diets also decreased infiltration of both macrophages and neutrophils into the esophagus. Overall, our results suggest that another mechanism by which BRBs, ACs, and PCA inhibit NMBA-induced esophageal tumorigenesis is by altering cytokine expression and innate immune cell trafficking into tumor tissues.


Subject(s)
Anthocyanins/administration & dosage , Antineoplastic Agents, Phytogenic/administration & dosage , Carcinoma, Squamous Cell/diet therapy , Esophageal Neoplasms/diet therapy , Administration, Oral , Animals , CD8-Positive T-Lymphocytes/immunology , Carcinoma, Squamous Cell/blood supply , Diet , Drug Screening Assays, Antitumor , Esophageal Neoplasms/blood supply , Esophagus/immunology , Esophagus/pathology , Fruit/chemistry , Immunity, Innate , Killer Cells, Natural/immunology , Macrophages/immunology , Male , Neovascularization, Pathologic/diet therapy , Neovascularization, Pathologic/immunology , Neutrophil Infiltration , Rats, Inbred F344 , Rats, Sprague-Dawley , Rubus/chemistry
2.
Nicotine Tob Res ; 17(6): 704-9, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25335945

ABSTRACT

INTRODUCTION: Electronic cigarettes (e-cigarettes) are rapidly increasing in popularity but little information is available on their potential toxic or carcinogenic effects. METHODS: Twenty-eight e-cigarette smokers who had not smoked tobacco cigarettes for at least 2 months provided urine samples which were analyzed by validated methods for a suite of toxicant and carcinogen metabolites including 1-hydroxypyrene (1-HOP), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides (total NNAL), 3-hydroxypropylmercapturic acid (3-HPMA), 2-hydroxypropylmercapturic acid (2-HPMA), 3-hydroxy-1-methylpropylmercapturic acid (HMPMA), S-phenylmercapturic acid (SPMA), nicotine, and cotinine. Levels of these compounds were compared to those found in cigarette smokers from three previous studies. RESULTS: Levels of 1-HOP, total NNAL, 3-HPMA, 2-HPMA, HMPMA, and SPMA were significantly lower in the urine of e-cigarette users compared to cigarette smokers. Levels of nicotine and cotinine were significantly lower in e-cigarette users compared to cigarette smokers in one study but not in another. CONCLUSIONS: With respect to the compounds analyzed here, e-cigarettes have a more favorable toxicity profile than tobacco cigarettes.


Subject(s)
Carcinogens/analysis , Electronic Nicotine Delivery Systems , Hazardous Substances/urine , Smoking/urine , Tobacco Products , Acetylcysteine/analogs & derivatives , Acetylcysteine/urine , Adult , Cotinine/urine , Female , Humans , Male , Middle Aged , Nicotine/urine , Nitrosamines/urine , Pyrenes/urine , Pyridines/urine , Young Adult
3.
Cancer Prev Res (Phila) ; 7(6): 574-84, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24667581

ABSTRACT

Diets containing either freeze-dried black raspberries (BRBs) or their polyphenolic anthocyanins (ACs) have been shown to inhibit the development of N-nitrosomethylbenzylamine (NMBA)-induced esophageal cancer in rats. The present study was conducted to determine whether PCA, a major microbial metabolite of black raspberry (BRB) ACs, also prevents NMBA-induced esophageal cancer in rats. F344 rats were injected with NMBA three times a week for 5 weeks and then fed control or experimental diets containing 6.1% BRBs, an anthocyanin (AC)-enriched fraction derived from BRBs, or protocatechuic acid (PCA). Animals were exsanguinated at weeks 15, 25, and 35 to quantify the development of preneoplastic lesions and tumors in the esophagus, and to relate this to the expression of inflammatory biomarkers. At weeks 15 and 25, all experimental diets were equally effective in reducing NMBA-induced esophageal tumorigenesis, as well as in reducing the expression of pentraxin-3 (PTX3), a cytokine produced by peripheral blood mononuclear cells in response to interleukin (IL)-1ß and TNF-α. All experimental diets were also active at reducing tumorigenesis at week 35; however, the BRB diet was significantly more effective than the AC and PCA diets. Furthermore, all experimental diets inhibited inflammation in the esophagus via reducing biomarker (COX-2, iNOS, p-NF-κB, and sEH) and cytokine (PTX3) expression. Overall, our data suggest that BRBs, their component ACs, and PCA inhibit NMBA-induced esophageal tumorigenesis, at least in part, by their inhibitory effects on genes associated with inflammation.


Subject(s)
Anticarcinogenic Agents/therapeutic use , Diet Therapy , Esophageal Neoplasms/prevention & control , Hydroxybenzoates/therapeutic use , Rubus , Animals , Anthocyanins/isolation & purification , Anthocyanins/metabolism , Anthocyanins/therapeutic use , Anticarcinogenic Agents/isolation & purification , Chemoprevention/methods , Dimethylnitrosamine/analogs & derivatives , Fruit , Hydroxybenzoates/isolation & purification , Male , Plant Extracts/therapeutic use , Precancerous Conditions/chemically induced , Precancerous Conditions/drug therapy , Rats , Rats, Inbred F344 , Rubus/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...